CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award See Remarks acquired 1,219,294 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award 10% owner acquired 322,225 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy PRESIDENT, CEO & CHAIRMAN bought 100,000 shares at $0.68 ($67,960)
- 4 Open-market buy PRESIDENT, CEO & CHAIRMAN bought 5,000 shares at $0.56 ($2,800)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.56 ($2,800)
- 4 Grant or award Chief Financial Officer acquired 1,350,000 shares (grant or award)
- 4 Open-market buy PRESIDENT, CEO & CHAIRMAN bought 100,000 shares at $0.70 ($69,500)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 5,000 shares at $2.45 ($12,250)
- 4 Open-market sale Chief Financial Officer sold 28,292 shares at $3.13 ($88,554)
- 4 Grant or award See Remarks acquired 1,102,986 shares (grant or award)
Page 5 of 15 · 289 filings